Ara
Toplam kayıt 1, listelenen: 1-1
Discontinuation Of Imatinib Mesylate Could Improve Renal Impairment In Chronic Myeloid Leukemia
(2019)
We aim to report a CML case that had fluid retention and serum creatinine increase under long-term imatinib mesylate (IM) treatment. A 68-year-old woman was diagnosed with chronic myeloid leukemia, and IM was started in ...